CRISIL
Crisil Limited (crisil): Resilient Performance Amidst Macro-economic Uncertainty
Crisil Limited (CRISIL) showcases resilient performance in Q3 FY27, maintaining leadership with best-in-class assessments.
Crisil Limited (CRISIL) has demonstrated resilient performance in Q3 FY27, maintaining its leadership position in the ratings industry despite macroeconomic uncertainties. The company’s revenue growth and profit margins have shown positive trends, driven by investor preference for its best-in-class assessments.
Global Macro-Economic Trends
Global GDP growth is expected to remain resilient at 3.2% in both 2026 and 2027, supported by strong consumer demand and AI-driven investment. However, inflation remains elevated, with the US CPI expected to stay above 3% for the rest of the year due to energy costs. India’s inflation is expected to rise to 5.3% in FY27, driven by higher energy and food prices.
Crisil’s Performance Update
Crisil Ratings continued to grow revenues and maintain its leadership position, despite a decline in bond issuances. The Global Analytics Center saw growth in delegation of surveillance support to S&P Global Ratings and expanded analytical and operational support to S&P in new areas. Crisil Coalition Greenwich focused on deepening client engagement and saw demand in Corporate and Investment Banking. Interim dividend of Rs 17 per share was declared in Q3 2026.
Financial Highlights
Profit before tax (PBT) increased by 20.2% in Q3 2026 and 5.3% in Q3 2026. Profit after tax (PAT) also showed a robust increase, reflecting the company’s strong financial health. These numbers underline Crisil’s ability to navigate through macroeconomic challenges and deliver consistent growth.
As Crisil moves forward, the company continues to scale its domain-led AI capabilities and focus on outcome-led partnerships to drive future growth and innovation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Crisil Limited
Crisil Limited belongs to the Financial Services › Financial Data & Stock Exchanges sector. Here’s a quick read on where the business and the stock stand today.
Crisil posts a 7.1% three-month gain, but softens in the last few weeks. The PEG reaches 3.51. The stock trades on brand and index weight, not on growth. Premium net margins of 21.4% demonstrate strong cost discipline and a wide competitive moat. The stock gives back 0.7% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The business grows revenue at 9.6% and profits at 10.7%, with D/E of 0.00. The stock reflects that strength. Moreover, when fundamentals and price action align, the PEG of 3.51 premium is usually justified. Check Fundamentals of Crisil Limited.
-
Healthcare2 days agoZydus Lifesciences Limited (zyduslife) Partners with Prolific Machines to Scale Biologics Manufacturing
-
AYE2 days agoAye Finance Limited (NSE: AYE) Q2fy27: Highest-ever Quarterly Profit of INR 87 Crore
-
Healthcare2 days agoNureca Limited (nureca) Q2 FY27: Revenue Up 55%, Records Highest Quarterly Revenue in Last 20 Quarters
-
Basic Materials2 days agoInternational Gemological Institute Limited (igil) Q2 FY27: Certification Revenue Up 32%, Ebitda Growth at 39%
-
INFOBEAN2 days agoInfobeans Technologies Limited (infobean) Achieves Select Partner Tier in the Claude Partner Network Services
-
Healthcare2 days agoZydus Lifesciences Limited (zyduslife) Receives USFDA Approval for Estradiol and Levonorgestrel
-
Conglomerates2 days agoSrf Limited (NSE: SRF) Reports Strong Growth in Q2 & H1 FY27
-
Information Technology Services2 days agoLtm Limited (LTM) Launches Blueverse™ Valuemesh™ to Help Enterprises Scale AI Across Oracle
